Spineology has announced that the US Patent and Trademark Office has issued a Notice of Allowance for its US Application Serial Number 12/650,889, entitled “System and method for performing percutaneous spinal interbody fusion.”
Reducing surgical invasiveness has been shown to reduce post-operative discomfort and long-term morbidity leading to reduced hospitalisation and quicker patient recovery. This patent covers methods of performing percutaneous spinal fusion procedures through an opening of less than one centimetre.
“The implant and instrumentation methods covered in this patent exemplify Spineology’s commitment to the development of a truly anatomy-conserving technology (ACT) product platform,” says John Booth, chief executive officer of Spineology. “This patent allowance establishes Spineology as the leader in percutaneous spinal fusion technology.”
“Percutaneous spinal access, discectomy, and fusion preserve anatomy, more so than any other surgical methodology,” says Karen Roche, vice president of Spineology research and development. “Preservation of bone, nerve and muscle significantly reduces surgical morbidity and can greatly aid in the improvement of surgical outcomes.”
